Dr. Ryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 1st Ave
New York, NY 10016Phone+1 212-212-7300
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2002 - 2003- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2001
- NYU Grossman School of MedicineResidency, Internal Medicine, 1996 - 1999
- New York University School of MedicineClass of 1996
Certifications & Licensure
NY State Medical License 1999 - 2026- American Board of Internal Medicine Medical Oncology
- American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer Start of enrollment: 2004 Jun 01
- Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer Start of enrollment: 2005 Jul 01
- Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07
Publications & Presentations
PubMed
- 206 citationsMaintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized P...Howard S. Hochster, Edie Weller, Randy D. Gascoyne, Thomas M. Habermann, Leo I. Gordon
Journal of Clinical Oncology. 2009-04-01 - 110 citationsPotent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.Sarah K. Tasian, David T. Teachey, Yong Li, Feng Shen, Richard C. Harvey
Blood. 2017-01-12 - 37 citationsRandomized phase 2 study of pegylated SN-38 (EZN-2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer.Christopher R. Garrett, Tanios Bekaii-Saab, Theresa Ryan, George A. Fisher, Sally Clive
Cancer. 2013-12-15
Press Mentions
Bad Fat, Misbehaving Kidneys May Share Common OffenderSeptember 16th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
